Shop

Author at Microdose

Microdose

At our core, we champion integrity, diversity, and objectivity, providing trusted content that unites a wide array of experts and fosters unbiased opinions, ultimately empowering the psychedelic medicine community to flourish and make a positive impact on the world.

Press Releases

18 Mar 2021

Tryp Therapeutics Announces Provisional Patent Filing For Improved Administration of Psychedelics

La Jolla, California–(Newsfile Corp....

By Microdose

Press Releases

17 Mar 2021

Field Trip Health Ltd. Announces Closing of $95 Million Bought Deal Financing

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, March 17, 2021 (GLOBE NEWSWIRE) — Field Trip Health Ltd....

By Microdose

Press Releases

17 Mar 2021

PSYC Expands Digital Media Presence with the Launch of the Industry’s First Video News Segment

Psychedelic Spotlight Debuts the Spotlight Roundup LAS VEGAS, NV, March 17, 2021 (GLOBE NEWSWIRE) — Global Trac Solutions, Inc....

By Microdose

Press Releases

17 Mar 2021

Mindset Pharma Announces DTC Eligibility for OTCQB(R) Venture Listing

Toronto, Ontario–(Newsfile Corp....

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Press Releases

16 Mar 2021

Pure Extracts Orders First Shipment of Functional Mushrooms for e-Commerce Store

VANCOUVER, British Columbia, March 16, 2021 (GLOBE NEWSWIRE) — Pure Extracts Technologies Corp....

By Microdose

Press Releases

16 Mar 2021

Mydecine Innovations Group Provides Update on European Operations

DENVER, March 16, 2021 (GLOBE NEWSWIRE) — Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), an emerging biopharma and life sciences company committed to the...

By Microdose

Press Releases

16 Mar 2021

New Wave Subsidiary, Way of Will Inc., Announces Receipt of Purchase Order for Nail & Cuticle Serum from Popular Self-Care Subscription Service…

TORONTO, ON, March 16, 2021 /CNW/ - NEW WAVE HOLDINGS CORP....

By Microdose

Press Releases

16 Mar 2021

Havn Life Introduces Industry Leader Jenna Pozar as Chief Operating Officer

Pozar will lead sales, marketing, e-commerce and logistics for Havn Retail Vancouver, BC – Havn Life Sciences Inc....

By Microdose

Press Releases

15 Mar 2021

Psyched Wellness Announces Changes to the Board of Directors

Toronto, Ontario–(Newsfile Corp....

By Microdose

Follow us on social

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

You Might Also Like

17 Dec 2025

Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward

If 2024 was the year the psychedelic field learned how hard “approval ready” really is, 2025 was the year it began behaving accordingly. The past twelve months were less about...

By Madison Roberts

26 Nov 2025

Delix Therapeutics Reports Strong Phase Ib Results

Delix Therapeutics recently announced compelling data from a Phase Ib trial of DLX-001 (zalsupindole), a non-hallucinogenic neuroplastogen. According to the company’s release, DLX-001 produced robust biomarker signals (quantitative EEG and...

By Madison Roberts

19 Nov 2025

Childhood Trauma’s Role in Men’s Substance Use Disorders

Childhood trauma leaves a deeper imprint on men’s lives than most realize—and for many, it becomes the hidden engine driving substance use disorders. Research shows that emotional abuse, physical violence,...

By Madison Roberts

19 Nov 2025

Human-Centered AI in Healthcare

Artificial intelligence is redefining modern healthcare, offering powerful tools that enhance diagnosis, expedite drug discovery, and enable truly personalized treatment. As health systems struggle with rising costs, aging populations, and...

By Madison Roberts

16 Oct 2025

Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up

As Big Pharma makes billion-dollar bets in the evolving landscape of neuropsychiatric therapeutics, Enveric Biosciences (NASDAQ: ENVB) is carving out a formidable position — not by chasing headlines, but by...

By Madison Roberts

15 Oct 2025

The IP Battle Behind the $1.2B Psychedelic Acquisition—and Why Enveric Biosciences Is a Name to Watch

Take Enveric Biosciences (NASDAQ: ENVB), a company that’s been flying under the radar while building an IP fortress around a novel class of non-hallucinogenic neuroplastogens. Now, that fortress is being...

By Madison Roberts
WordPress Ads
No Result
View All Result

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.